• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Lasa Supergenerics Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 67941.0
  • ISIN : INE670X01014
16.85 0 (-2.38%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    16.80

  • Today’s High

    18.24

  • Open

    17.20

  • Perv Close

    17.26

  • 52W Low

    16.80

  • 52W High

    33.49

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    84.42

  • Div & Yield %

    0.00

  • Book Value(₹)

    18.11

  • Debt-Equity Ratio

    -2.38

  • AGM Date

    28-Mar-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    84.42

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    50.10

  • BV (₹)

    18.10

  • Sales( ₹ in Cr.)

    104.34

  • NP (in Cr.)

    -14.16

  • NP Var(%)

    27.0

  • Div%

    0.0

  • CPS (₹)

    -0.70

  • EPS (₹)

    -2.80

  • Traded Value (₹ in Lakhs)

    84.42

  • 52 Week High

    33.49

  • 52 Week Low

    16.80

  • Price BSE

    17.0

  • Price NSE

    17.00

  • Market Capital( in Cr.)

    84.42

  • P/C Ratio

    -24.40

  • P/E Ratio

    -6.00

  • Price Vs.BV

    -2.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 104.34 129.57 137.13 202.38 167.27 169.57
Excise Duty 104.34 129.57 137.13 202.38 167.27 169.57
Net Sales 104.34 129.57 137.13 202.38 167.27 169.57
Other Income 0.10 1.80 0.27 0.06 0.23 0.47
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 104.43 131.37 137.40 202.44 167.49 170.05
EXPENDITURE :
Raw Materials 104.34 129.57 137.13 202.38 167.27 169.57
Power & Fuel Cost 104.34 129.57 137.13 202.38 167.27 169.57
Employee Cost 6.34 7.37 7.15 14.01 13.42 11.74
Other Manufacturing Expenses 0.48 2.76 1.24 1.08 6.84 1.37
Selling & Administrative Expenses 4.80 5.99 9.05 10.21 6.65 4.73
Miscellaneous Expenses 0.48 2.76 1.24 1.08 6.84 1.37
Less : Pre-operative Expenses Capitalised :
Total Expenditure 114.77 153.74 135.68 172.95 162.75 186.15
Operating Profit 15.33 13.93 12.40 17.51 15.75 12.68
Interest 1.93 4.16 0.04 1.96 8.10 8.38
Gross Profit -19.11 -42.27 -6.14 29.49 4.74 -16.10
Depreciation 10.67 13.42 14.51 15.82 17.34 19.31
Profit Before Tax -19.11 -42.27 -6.14 29.49 4.74 -16.10
Tax 0.00 0.00 0.03 1.97 0.91 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 2.62 -3.69 -1.46 5.65 -0.17 -4.68
Reported Net Profit -21.73 -38.62 -5.33 22.78 3.63 -12.03
Extraordinary Items -19.11 -42.27 -6.14 29.49 4.74 -16.10
Adjusted Net Profit -21.73 -38.62 -5.33 22.78 3.63 -12.03
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 1.02 1.02 0.00 0.00
P & L Balance carried down -21.73 -38.62 -5.33 22.78 3.63 -12.03
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 2.50 2.50 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.25 0.25 0.00 0.00
Earnings Per Share-Unit Curr -4.34 -7.71 -1.06 5.60 0.89 -5.26
Book Value 0.00 0.00 1.02 1.02 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 1.02 1.02 0.00 0.00

Shareholding Pattern

  • Promoter Group

    53.65%

  • Public Share Holding

    46.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 26,879,660 53.65 26,879,660 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 26,879,660 53.65 26,879,660 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 4,781,150 9.54 4,781,150 98
Clearing Members 86,266 0.17 86,266 18
Directors of their Relatives 41,225 0.08 41,225 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 396,086 0.79 395,136 299
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 824,891 1.65 824,891 612
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,856,439 7.70 3,856,439 78
Individuals holding nominal share capital up to Rs. 1 lakh 13,235,511 26.42 13,232,490 26,163
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 11 0.00 11 1
Others 0 0.00 0 0
Sub Total 23,221,579 46.35 23,217,608 27,271
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 50,101,239 100.00 50,097,268 27,272

Company Background

Lasa Supergenerics LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Lasa Supergenerics Ltd
  • BSE Code : 67941.0
  • ISIN : INE670X01014

  • Incorporation Year

    2016

  • Registered Office

    C-105 MIDC
    Mahad, Raigad,
    Maharashtra-402301

  • Telephone

    91-2145-232101/232202

  • FAX

  • Chairman

    Omkar P Herlekar

  • Managing Director

    Omkar P Herlekar

  • Company Secretary

    Mitti M Jain

  • Auditor

    Thanawala & Co/Gupta Rustagi & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Lasa Supergenerics Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Lasa Supergeneri 16.85 104.43 104.34 -5.35 0.00
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92